L B Travis

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi Mortality after cerebral angiography with or without radioactive Thorotrast: an international cohort of 3,143 two-year survivors
    L B Travis
    Radiation Epidemiology Branch, National Cancer Institute, Bethesda, Maryland 20892, USA
    Radiat Res 156:136-50. 2001
  2. ncbi Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease
    Lois B Travis
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA
    J Natl Cancer Inst 94:182-92. 2002
  3. ncbi Clinical features of hematopoietic malignancies and related disorders among benzene-exposed workers in China. Benzene Study Group
    M S Linet
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland 20892 7368, USA
    Environ Health Perspect 104:1353-64. 1996
  4. ncbi Lung cancer after treatment for Hodgkin's disease: focus on radiation effects
    E S Gilbert
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda Maryland 20852 7238, USA
    Radiat Res 159:161-73. 2003
  5. ncbi Risk of treatment-related esophageal cancer among breast cancer survivors
    L M Morton
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Rockville, MD 20892, USA
    Ann Oncol 23:3081-91. 2012
  6. ncbi Lung cancer after Hodgkin lymphoma: the roles of chemotherapy, radiotherapy and tobacco use
    L B Travis
    Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI, National Institutes of Health, Bethesda, Maryland, USA
    Radiat Res 163:695-6. 2005
  7. ncbi Cancer risk following exposure to Thorotrast: overview in relation to a case report
    L B Travis
    Radiation Epidemiology Branch, National Cancer Institute, National Institutes of Health, U S Department of Health and Human Services, Rockville, MD 20852
    Health Phys 63:89-97. 1992
  8. ncbi Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study
    R E Curtis
    Division of Cancer Epidemiology, Laboratory of Pathology, National Cancer Institute, Bethesda, MD, USA
    Blood 94:2208-16. 1999
  9. ncbi Mortality among benzene-exposed workers in China
    R B Hayes
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892 7368, USA
    Environ Health Perspect 104:1349-52. 1996
  10. ncbi Solid tumors after chronic lymphocytic leukemia
    M Hisada
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20852, USA
    Blood 98:1979-81. 2001

Collaborators

Detail Information

Publications11

  1. ncbi Mortality after cerebral angiography with or without radioactive Thorotrast: an international cohort of 3,143 two-year survivors
    L B Travis
    Radiation Epidemiology Branch, National Cancer Institute, Bethesda, Maryland 20892, USA
    Radiat Res 156:136-50. 2001
    ..The cumulative excess risk of cancer death remained high up to 50 years after injection with >20 ml Thorotrast and approached 50%...
  2. ncbi Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease
    Lois B Travis
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA
    J Natl Cancer Inst 94:182-92. 2002
    ..We quantified the risk of treatment-associated lung cancer, taking into account tobacco use...
  3. ncbi Clinical features of hematopoietic malignancies and related disorders among benzene-exposed workers in China. Benzene Study Group
    M S Linet
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland 20892 7368, USA
    Environ Health Perspect 104:1353-64. 1996
    ....
  4. ncbi Lung cancer after treatment for Hodgkin's disease: focus on radiation effects
    E S Gilbert
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda Maryland 20852 7238, USA
    Radiat Res 159:161-73. 2003
    ....
  5. ncbi Risk of treatment-related esophageal cancer among breast cancer survivors
    L M Morton
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Rockville, MD 20892, USA
    Ann Oncol 23:3081-91. 2012
    ..Radiotherapy for breast cancer may expose the esophagus to ionizing radiation, but no study has evaluated esophageal cancer risk after breast cancer associated with radiation dose or systemic therapy use...
  6. ncbi Lung cancer after Hodgkin lymphoma: the roles of chemotherapy, radiotherapy and tobacco use
    L B Travis
    Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI, National Institutes of Health, Bethesda, Maryland, USA
    Radiat Res 163:695-6. 2005
  7. ncbi Cancer risk following exposure to Thorotrast: overview in relation to a case report
    L B Travis
    Radiation Epidemiology Branch, National Cancer Institute, National Institutes of Health, U S Department of Health and Human Services, Rockville, MD 20852
    Health Phys 63:89-97. 1992
    ..The skeleton of USUR Case 1001, however, contained significant levels of radioactivity. Other tissues evaluated in USUR Case 1001 included lung, eye, kidney, and breast, which did not contain elevated levels of radioactivity...
  8. ncbi Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study
    R E Curtis
    Division of Cancer Epidemiology, Laboratory of Pathology, National Cancer Institute, Bethesda, MD, USA
    Blood 94:2208-16. 1999
    ..0% +/- 2.9% and 22% +/- 17.9%, respectively. We conclude that factors associated with altered immunity and T-cell regulatory mechanisms are predictors of both early- and late-onset PTLD...
  9. ncbi Mortality among benzene-exposed workers in China
    R B Hayes
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892 7368, USA
    Environ Health Perspect 104:1349-52. 1996
    ..01) and lung cancer (ptrend = 0.01) increased with increasing cumulative exposure to benzene. Investigations continue to relate benzene exposure to specific lymphatic and hematopoietic malignancies and other causes of death...
  10. ncbi Solid tumors after chronic lymphocytic leukemia
    M Hisada
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20852, USA
    Blood 98:1979-81. 2001
    ..91) and for cancers of the stomach (O/E = 1.76) and bladder (O/E = 1.52) among women. Additional investigations of cancers after CLL are needed to explore the role of immunologic impairment and/or other etiologic influences...
  11. ncbi Polymorphic MLH1 and risk of cancer after methylating chemotherapy for Hodgkin lymphoma
    L J Worrillow
    Department of Biology, University of York, Heslington, York, UK
    J Med Genet 45:142-6. 2008
    ..We hypothesised that a common substitution in the basal promoter of MLH1 (position -93, rs1800734) modifies the risk of cancer after methylating chemotherapy...